Abstract:Héctor Gallardo-Rincón, 1, 2 Julieta Lomelin-Gascon, 2 Luis Alberto Martinez-Juarez, 2 Alejandra Montoya, 2 Janinne Ortega-Montiel, 2 Victoria Galicia-Hernandez, 2 Diego-Abelardo Álvarez-Hernández, 2 Rosangela Ávila-Domínguez, 2 Enrique Reyes-Muñoz, 3 Lucía Marcela Illescas-Correa, 4 Daniel Alberto Diaz Martinez, 5 Francisco Javier Magos Vázquez, 5 Edwin Oswaldo Vargas Ávila, 5 Alejandro Efraín Benitez-Herrera, 6 Diana Reyes-Gómez, 6 María Concepción Carmona-Ramos, 6 Laura Hernández-González, 6 Oscar Romero-Islas, 6 Ricardo Mújica-Rosales, 2 Roberto Tapia-Conyer 7 1 University of Guadalajara, Health Sciences University Center, Guadalajara, Jalisco, Mexico; 2 Carlos Slim Foundation, Mexico City, Mexico; 3 Coordination of Gynecological and Perinatal Endocrinology, National Institute of Perinatology, Mexico City, Mexico; 4 Maternal and Childhood Research Center (CIMIGEN), Mexico City, Mexico; 5 Ministry of Health of the State of Guanajuato, Guanajuato, Mexico; 6 Ministry of Health of the State of Hidalgo, Pachuca, Hidalgo, Mexico; 7 National Autonomous University of Mexico, School of Medicine, Mexico City, Mexico Correspondence: Luis Alberto Martinez-Juarez, Carlos Slim Foundation, Lago Zurich 245, Presa Falcon Building (Floor 20), Miguel Hidalgo, Mexico City, 11529, Mexico, Tel +52 55 53 39 17 70, Fax +52 55 53 39 17 70, Email Purpose: Few pregnant women in low-resource settings are screened for gestational diabetes mellitus (GDM) using the gold standard oral glucose tolerance test (OGTT). This study compared capillary blood glucose testing with 2-h plasma glucose measurements obtained using the 75-g OGTT to screen for GDM at primary healthcare clinics in Mexico. Patients and Methods: Pregnant women who participated in a previous prospective multicenter longitudinal cohort study and who had not been previously diagnosed with diabetes were included. Participants were evaluated using the plasmatic 2-h 75-g OGTT with simultaneous capillary blood glucose measurements using a glucometer. The study endpoint was the comparability of the glucometer results to the gold standard OGTT when collected simultaneously. Sensitivity, specificity, and area under the curve of the glucose measurements obtained for capillary blood compared with venous plasma (gold standard) were calculated to determine diagnostic accuracy. Results: The study included 947 pregnant women who had simultaneous glucose measurements available (blood capillary [glucometer] and venous blood OGTT). Overall, capillary blood glucose testing was very sensitive (89.47%); the specificity was 66.58% and the area under the curve (95% confidence interval) was 0.78 (0.74– 0.81). The sensitivity, specificity and area under the curve of each capillary measurement were: 89.47%, 66.58% and 0.78 (0.74– 0.82) for the fasting measurement, 91.53%, 93.24% and 0.92 (0.88– 0.96) for the one-hour measurement, and 89.80%, 93.32%, 0.91 (0.87– 0.95) for the second-hour measurement, respectively. No adverse events were reported. Conclusion: Capillary OGTT is a valid alternative to the gold standard OGTT for screening of GDM in low-resource situations or in situations where there are other limitations to performing the OGTT as part of primary healthcare services. Keywords: capillary blood glucose, gestational diabetes mellitus, low-resource, Mexico, oral glucose tolerance test, screening Gestational diabetes mellitus (GDM) is a condition diagnosed during pregnancy that was not clearly overt diabetes prior to gestation. 1 GDM is a neglected risk to the health of both mothers and children and can lead to numerous pregnancy-related complications including babies with a larger birth weight, high blood pressure, and obstructed labor. 2 Approximately half of women who experience GDM subsequently develop type 2 diabetes mellitus in the 5–10 years after their baby is delivered. 2 The estimated global prevalence of GDM in 2021 was between 4.3% and 38.1%. 3 The prevalence for North America and the Caribbean is reported to be 20.7%, 4 and in Mexico, while data are insufficient to determine the national prevalence of GDM, it is estimated to be between 10% and 12%. 5,6 Screening and diagnostic strategies for GDM have been a focus of international debate. 7,8 Currently, the 75-g oral glucose tolerance test (OGTT) is considered the gold standard for diagnosing GDM. The American Diabetes Association (ADA) recommends OGTT with three plasma glucose measurements (fastin -Abstract Truncated-

Problems in screening for gestational diabetes mellitus by measurement of casual blood glucose levels at 24–28 gestational weeks

Use of capillary blood glucose for screening for gestational diabetes mellitus in resource-constrained settings

Screening for gestational diabetes mellitus in Nigerian pregnant women using fifty-gram oral glucose challenge test

Difference Between 2 H and 3 H 75 G Glucose Tolerance Test in the Diagnosis of Gestational Diabetes Mellitus (GDM): Results from a National Survey on Prevalence of GDM

Study for the criteria of screening tests for gestational diabetes mellitus

Current status of screening and management of gestational diabetes in early pregnancy: a questionnaire survey in Japan

[Study of 8,665 Cases of the 50 G Oral Glucose Challenge Test to Screen the Gestational Diabetes Mellitus].

Cut-off value for glucose challenge test in Chinese women during pregnancy

Use of the Japanese gestational diabetes mellitus diagnostic strategy during the COVID‐19 pandemic in Japan: A questionnaire survey

Screening for gestational diabetes mellitus. Use and accuracy of capillary blood glucose measured with a reflectance meter

Diagnostic Accuracy of Capillary Blood Glucometer Testing for Gestational Diabetes

Clinical utility of point‐of‐care glucose testing in the assessment of gestational diabetes: Prospective cohort study

Prevalence of gestational diabetes mellitus based on various screening strategies in western Kenya: a prospective comparison of point of care diagnostic methods

1174-P: Characterization of Glucose Levels in Pregnancy Measured by Blood Glucose Testing or CGM Monitoring after a 50-g Screening or a 75-g or 100-g OGTT

[Early Glucose Challenge Test in Pregnant Women with Risk Factors of GDM in China].

Value of Fasting Plasma Glucose to Screen Gestational Diabetes Mellitus Before the 24th Gestational Week in Women with Different Pre-Pregnancy Body Mass Index.

Analysis Of Oral Glucose Tolerance Test In Pregnant Women With Abnormal Glucose Metabolism

Fasting blood glucose as a screening measure for late-onset gestational diabetes in the third trimester

Magnitude of Gestational Diabetes Mellitus, its Influencing Factors and Diagnostic Accuracy of Capillary Blood Testing for its Detection at a Tertiary Care Centre, Rajkot, Gujarat

Analysis of 2864 Cases of Pregnant Women in a Single Center Results of Oral 75 G Anhydrous Glucose Tolerance Test

Research on the Effect of Glucose Tolerance Screening on the Prognosis of Mothers and Infants in Different Gestational Ages